FdaApplication

NDA 220185

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNUVALENT INC
application_typeNDA
approval_date2026-07-22

Products (2)

ProductActive ingredientStrengthDosage form
JIDEYTROZIDESAMTINIB25MGTABLET;ORAL
JIDEYTROZIDESAMTINIB100MGTABLET;ORAL

2 products